Both prothioconazole and tebuconazole belong to FRAC Group 3 and primarily act by inhibiting the C14 demethylation step in the sterol biosynthesis pathway of pathogenic fungi, thereby disrupting normal cell membrane formation.
Although both active ingredients share the same primary mode of action, there may be some differences in their activity against pathogens and their performance in practical applications.
This combination can be used to develop fungicide products targeting certain fungal diseases of cereals; relevant applications may include rust, leaf spot and other locally approved diseases.
It should be noted that both prothioconazole and tebuconazole are DMI-class fungicides; this formulation must not be marketed as a resistance management strategy incorporating two distinct modes of action.
If pathogens with reduced sensitivity to DMIs are already present in the target market, appropriate rotation with fungicides from other FRAC Groups should be implemented.
Supply Information
MaFa Agro provides supply consultancy for Prothioconazole 20% + Tebuconazole 20% SC and can coordinate packaging, labelling and technical documentation according to the importer’s requirements.
We assist clients in confirming product specifications, quality requirements and export procurement conditions for their target markets.